KFC
IBB icon

Klingenstein Fields & Co’s iShares Biotechnology ETF IBB Stock Holding History

Klingenstein Fields & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,492
Closed -$217K – 185
2024
Q3 		$217K Hold
1,492
– – 0.01% 180
2024
Q2 		$205K Sell
1,492
-79
-5% -$10.5K 0.01% 180
2024
Q1 		$216K Sell
1,571
-16
-1% -$2.19K 0.01% 180
2023
Q4 		$216K Buy
+1,587
New +$194K 0.01% 174
2023
Q2 		– Sell
-1,571
Closed -$203K – 172
2023
Q1 		$203K Sell
1,571
-100
-6% -$13.1K 0.01% 165
2022
Q4 		$219K Buy
+1,671
New +$216K 0.01% 167
2022
Q2 		– Sell
-1,671
Closed -$218K – 179
2022
Q1 		$218K Sell
1,671
-459
-22% -$59.8K 0.01% 180
2021
Q4 		$325K Sell
2,130
-450
-17% -$69.7K 0.01% 153
2021
Q3 		$417K Hold
2,580
– – 0.02% 146
2021
Q2 		$422K Sell
2,580
-100
-4% -$15.4K 0.02% 148
2021
Q1 		$404K Hold
2,680
– – 0.02% 145
2020
Q4 		$406K Hold
2,680
– – 0.02% 145
2020
Q3 		$363K Hold
2,680
– – 0.02% 145
2020
Q2 		$366K Hold
2,680
– – 0.02% 141
2020
Q1 		$289K Hold
2,680
– – 0.02% 146
2019
Q4 		$323K Hold
2,680
– – 0.02% 159
2019
Q3 		$267K Hold
2,680
– – 0.01% 166
2019
Q2 		$292K Hold
2,680
– – 0.02% 166
2019
Q1 		$300K Sell
2,680
-130
-5% -$14.3K 0.02% 167
2018
Q4 		$271K Buy
2,810
+260
+10% +$27.6K 0.01% 169
2018
Q3 		$311K Hold
2,550
– – 0.01% 173
2018
Q2 		$280K Hold
2,550
– – 0.01% 181
2018
Q1 		$272K Hold
2,550
– – 0.01% 181
2017
Q4 		$272K Hold
2,550
– – 0.01% 194
2017
Q3 		$284K Hold
2,550
– – 0.01% 179
2017
Q2 		$264K Hold
2,550
– – 0.01% 190
2017
Q1 		$249K Sell
2,550
-705
-22% -$67.5K 0.01% 197
2016
Q4 		$288K Sell
3,255
-1,905
-37% -$173K 0.01% 189
2016
Q3 		$498K Buy
+5,160
New +$491K 0.02% 148

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Klingenstein Fields & Co's IBB Position: Q4 2024 in Review

Klingenstein Fields & Co sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,492 shares — an estimated $217K sold.

Klingenstein Fields & Co first reported a position in IBB in Q3 2016 and held it in 29 quarters. The position peaked at $498K in Q3 2016. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Klingenstein Fields & Co reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Klingenstein Fields & Co sold 1,492 iShares Biotechnology ETF shares in Q4 2024, an estimated $217K.
  • Klingenstein Fields & Co first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 29 quarters.
  • Klingenstein Fields & Co's iShares Biotechnology ETF position peaked at $498K in Q3 2016.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Klingenstein Fields & Co's 13F filing for Q4 2024, filed 30 Jan 2025.